I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
4-Phenoxyphenylacetonitrile is involved in the preparation of 2-(4-phenoxybenzoyl)-5-hydroxyindole, which is used as aCa2+/calmodulin-dependent protein kinase II (CaMKII) inhibitor.
Komiya, M.; Asano, S.; Koike, N.; Koga, E.; Igarashi, J.; Nakatani, S.; Isobe, Y. Synthesis of Novel Benzo-Fused Heteroaryl Derivatives as Ca2+/Calmodulin-Dependent Protein Kinase II Inhibitors. Chem. Pharm. Bull. 2013, 61 (10), 1094-1097.
Azam, F.; Prasad, M. V. V.; Thangavel, N. Structure-based design, synthesis, and molecular modeling studies of 1-(benzo[d]thiazol-2-yl)-3-(substituted aryl)urea derivatives as novel anti-Parkinsonian agents. Med. Chem. Res. 2012, 21 (9), 2630-2643.
Gefahrenhinweise (EU): H302
Harmful if swallowed.
Do not breathe dust/fume/gas/mist/vapours/spray. Obtain special instructions before use. Wear protective clothing. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.